|
Market Closed -
London S.E.
11:35:24 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 4.850 GBX | -1.02% |
|
+11.49% | -50.76% |
| 08-20 | Shield Therapeutics loss shrinks as milestone, royalty receipts grow | AN |
| 08-20 | Shield Therapeutics plc Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- STX Stock
- Consensus Shield Therapeutics plc
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
